C12Y 108/01009
Thioredoxin-disulfide reductase , i.e. thioredoxin-reductase
Official title: Thioredoxin-disulfide reductase (1.8.1.9), i.e. thioredoxin-reductase
C12Y108/01009 (Thioredoxin-disulfide reductase , i.e. thioredoxin-reductase) appears on 38 US grants and 52 published applications in this corpus.
Search patents in C12Y- Granted patents
- 38
- Published applications
- 52
- Assignees
- 40
- Inventors
- 108
- Latest grant
- 14 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 1 |
| 2003 | 5 | 4 |
| 2004 | 1 | 3 |
| 2005 | 1 | 1 |
| 2006 | 2 | 1 |
| 2007 | 1 | 0 |
| 2008 | 0 | 1 |
| 2009 | 1 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 2 |
| 2012 | 0 | 2 |
| 2013 | 0 | 2 |
| 2014 | 3 | 2 |
| 2015 | 1 | 1 |
| 2016 | 2 | 3 |
| 2017 | 1 | 3 |
| 2018 | 0 | 6 |
| 2019 | 1 | 1 |
| 2020 | 5 | 1 |
| 2021 | 1 | 3 |
| 2022 | 2 | 2 |
| 2023 | 0 | 5 |
| 2024 | 0 | 3 |
| 2025 | 5 | 2 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Biocatalyst as a core component of an enzyme-catalyzed redox system for the biocatalytic reduction of cystine14 Apr 2026US 12,600,995 B2Wacker Chemie AG
- E. coli strains having an oxidative cytoplasm9 Sep 2025US 12,410,393 B2Sutro Biopharma, Inc.
- Product and process for mucus viscosity normalization19 Aug 2025US 12,390,511 B2Orpro Therapeutics, Inc.
- Seminaphthofluorophore-selenium probes for thioredoxin reductase15 Jul 2025US 12,358,923 B2Portland State University
- Metabolic enzyme activity and disulfide bond reduction during protein production10 Jun 2025US 12,325,875 B2Bristol-Myers Squibb Company
- E. coli strains having an oxidative cytoplasm19 Mar 2026US 2026/0078337 A1Sutro Biopharma, Inc.
- Product and process for mucus viscosity normalization29 Jan 2026US 2026/0027189 A1Orpro Therapeutics, Inc.
- Enzyme electrode, reduction device, reduction method, modified protein, and modified protein production method8 May 2025US 2025/0145972 A1Panasonic Intellectual Property Management Co., Ltd.
- Enzyme electrode, enzymatic reaction device, enzymatic reaction method, modified protein, and modified protein production method8 May 2025US 2025/0146042 A1Panasonic Intellectual Property Management Co., Ltd.
- Modified human serum albumin-thioredoxin fusion body9 May 2024US 2024/0148839 A1KM Biologics Co., Ltd.
Most cited
By later US patents
- Grain processing method and transgenic plants useful therein19US 6,531,648 B1Syngenta Participations AG · 2003
- Neutralization of food allergens by thioredoxin18US 5,792,506 AThe Regents of the University of California · 1998
- Increasing the digestibility of food proteins by thioredoxin reduction15US 5,952,034 AThe Regents of the University of California · 1999
- Product and process for liquefaction of mucus or sputum12US 7,195,766 B2National Jewish Medical and Research Center · 2007
- Neutralization of food allergens by thioredoxin8US 6,190,723 B1The Regents of the University of California · 2001